Abstract
The standardized (NCCLS, ICS, DIN etc.) disk diffusion method is the most widespread technique for antibiotic susceptibility testing. Interpretive zone breakpoints are calculated from the regular regression line between minimum inhibitory concentrations (MIC) of bacterial isolates and the corresponding inhibition zone diameters around the disk containing the antibiotic. Studies of the regression line has revealed marked differences between different bacterial species. A newly described equation, the single strain regression analysis (SRA) equation, can be used to determine the regression line constants for individual strains. This method was applied to ciprofloxacin and S. aureus, E. faecalis, E. coli, P. mirabilis, P. aeruginosa, and P. maltophilia. The slope and intercept constants were determined for all 40 strains and showed a strong similarity within each species. A close similarity was also observed between the two Pseudomonas species and between S. aureus and E. faecalis. When the regression lines calculated by SRA for individual strains were extrapolated towards higher MIC values, the lines obtained for the more susceptible strains predicted the zones of more resistant strains within the species. The applications of SRA to several other antibiotics and bacterial species in earlier studies were reviewed. One exception to the predictive power of SRA has been detected earlier, H. influenzae and erythromycin. This led to the formulation of the standard curve regression analysis (SCA) equation which requires the use of two or more strains. Methodological aspects of SRA/SCA applications were presented. Three areas are particularly well suited for the use of SRA/SCA: 1. Calculation of interpretive zone breakpoints corresponding to recommended MIC limits in the individual laboratory. 2. Analysis of the effects of various disk contents of antibiotic on the resulting inhibition zones for various bacteria when new antibiotics are introduced. 3. Analytical tool as part of external quality control programmes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.